Abiopharma

🔍 Monia Brett P (Director)

Company: IONIS PHARMACEUTICALS INC (IONS)

Report Date: 2025-09-03

Detailed Transactions and Holdings:

• Acquired 102,900 shares of Common Stock at $53.77 per share (Direct)
  Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 282,909.00 | transaction_form_type: 4
• Sold 16,615 shares of Common Stock at $59.119 per share (Direct)
  Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 266,294.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 42,030 shares of Common Stock at $37.58 per share (Direct)
  Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 308,324.00 | transaction_form_type: 4
• Sold 127,500 shares of Common Stock at $60.1337 per share (Direct)
  Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 180,824.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Acquired 31,316 shares of Common Stock at $32.6 per share (Direct)
  Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 212,140.00 | transaction_form_type: 4
• Acquired 27,568 shares of Common Stock at $32.6 per share (Direct)
  Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 239,708.00 | transaction_form_type: 4
• Sold 59,699 shares of Common Stock at $61.0629 per share (Direct)
  Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 180,009.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 31,316 shares of Non-Qualified Stock Option (right to buy) at $32.6 per share (Derivative)
  Date: 2025-09-03 | Code: M | Expires: 2032-01-02 | Exercise: 2023-01-03 | equity_swap_involved: 0 | shares_owned_after: 67,741.00 | transaction_form_type: 4
• Sold 27,568 shares of Non-Qualified Stock Option (right to buy) at $32.6 per share (Derivative)
  Date: 2025-09-03 | Code: M | Expires: 2032-01-02 | Exercise: 2023-01-03 | equity_swap_involved: 0 | shares_owned_after: 40,173.00 | transaction_form_type: 4
• Sold 42,030 shares of Non-Qualified Stock Option (right to buy) at $37.58 per share (Derivative)
  Date: 2025-09-03 | Code: M | Expires: 2033-01-02 | Exercise: 2024-01-03 | equity_swap_involved: 0 | shares_owned_after: 76,643.00 | transaction_form_type: 4
• Sold 102,900 shares of Non-Qualified Stock Option (right to buy) at $53.77 per share (Derivative)
  Date: 2025-09-03 | Code: M | Expires: 2026-01-01 | Exercise: 2020-01-02 | equity_swap_involved: 0 | transaction_form_type: 4

Footnotes:

• F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.57 to $59.55 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.60 to $60.57 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.61 to $61.48 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4.